Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

The EU Establishes a New Supply Chain to Address the 'Visudyne' Shortage Problems

The European Medicines Agency (EMA) has reported the establishment of a new supply chain to address the shortage of 'Visudyne' (verteporfin), a medicine used for injection against serious eye conditions such as age-related macular degeneration in its moist form and choroid neovascularization caused by pathological myopia.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

5 Articles

diarioestrategia.cldiarioestrategia.cl
+4 Reposted by 4 other sources

The European Medicines Agency (EMA) has reported the establishment of a new supply chain to address the shortage of 'Visudyne' (verteporfin), a medicine used for injection against serious eye conditions such as age-related macular degeneration in its moist form and choroid neovascularization caused by pathological myopia.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

diarioestrategia.cl broke the news on Monday, September 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal